MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3899/jrheum.160688

Медицинская библиотека · The Journal of rheumatology · 2016

Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.

Huber Adam M, Kim Susan, Reed Ann M, Carrasco Ruy, Feldman Brian M, Hong Sandy D, Kahn Philip, Rahimi Homaira, Robinson Angela Byun, Vehe Richard K, Weiss Jennifer E, Spencer Charles, Juvenile Dermatomyositis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance

СтатьяConsensus StatementПеревод в очереди

Аннотация

OBJECTIVE

Juvenile dermatomyositis (JDM) is the most common form of idiopathic inflammatory myopathy in children. While outcomes are generally thought to be good, persistence of skin rash is a common problem. The goal of this study was to describe the development of clinical treatment plans (CTP) for children with JDM characterized by persistent skin rash despite complete resolution of muscle involvement.

METHODS

The Childhood Arthritis and Rheumatology Research Alliance, a North American consortium of pediatric rheumatologists and other healthcare providers, used a combination of Delphi surveys and nominal group consensus meetings to develop CTP that reflected consensus on typical treatments for patients with JDM with persistent skin rash.

RESULTS

Consensus was reached on patient characteristics and outcome assessment. Patients should have previously received corticosteroids and methotrexate (MTX). Three consensus treatment plans were developed. Plan A added intravenous immunoglobulin (IVIG) if it was not already being used. Plan B added mycophenolate mofetil, while Plan C added cyclosporine. Continuation of previous treatments, including corticosteroids, MTX, and IVIG, was permitted in plans B and C.

CONCLUSION

Three consensus CTP were developed for use in children with JDM and persistent skin rash despite complete resolution of muscle disease. These CTP reflect typical treatment approaches and are not to be considered treatment recommendations or standard of care. Using prospective data collection and statistical methods to account for nonrandom treatment assignment, it is expected that these CTP will be used to allow treatment comparisons, and ultimately determine the best treatment for these patients.

Для цитирования: Huber Adam M, Kim Susan, Reed Ann M, Carrasco Ruy, Feldman Brian M, Hong Sandy D, Kahn Philip, Rahimi Homaira, Robinson Angela Byun, Vehe Richard K, Weiss Jennifer E, Spencer Charles, Juvenile Dermatomyositis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.. The Journal of rheumatology. 2016. DOI: 10.3899/jrheum.160688.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.